Naturesfynd
Chicago, US · 2 known investors
The Fynder Group develops a biotechnology platform using extremophile fungi to produce specialty ingredients, biopharmaceutical drugs, and bio-based materials for food, beverage, pharmaceutical, and textile applications. The company leverages proprietary filamentous fungal strains to engineer high-performance solutions across multiple industries.
BiotechFoodTechNew Materials